Olema Oncology

0 followers

‌

Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor... Read more

Industries

Headquarters

San Francisco, United States

Employees

Links

Org chart

President & CEO

Sean P. Bohen

Collapse

Naseem Zojwalla

Chief Medical Officer

Chief Operating & Financial Officer

Chief Development Officer

VP, Finance & Controller

VP & Head of People

VP, Information Technology

VP, CMC

Kamesh Kuchimanchi

VP, Regulatory Affairs & Quality Assurance

Geoffrey Mogilner

VP, Investor Relations & Communications

Chief Scientific Officer

Kristin Lowland Lanzi

VP Of IT At Olema Oncology

Graham Walmsley

Board Director (nasdaq: Olma)

Board Member

Teams

Leadership Team

7 members

Clinical Development Team

13 members

Clinical and Pharmacology

9 members

Similar companies

SpringWorks Therapeutics

5 followers

Halozyme Therapeutics

4 followers

Prime Medicine

3 followers

Generation Bio

2 followers

Celldex Therapeutics

2 followers

Rigel Pharmaceuticals

2 followers

Viridian Therapeutics

2 followers

Modern Meadow

2 followers

Vividion Therapeutics

1 follower

Mersana Therapeutics

1 follower

ReCode Therapeutics

1 follower

Explore companies